probucol
Probucol, sold under the trade name Lorelco among others, is an anti-hyperlipidemic drug initially developed for the treatment of coronary artery disease. Clinical development was discontinued after it was found that the drug may have the undesired effect of lowering HDL in patients with a previous history of heart disease. It may also cause QT interval prolongation. Probucol was initially developed in the 1970s by a chemical company to maximize airplane tire longevity.
chemical compound
bisphenol medication chemical compound